Draft guidelines from the United States Preventative Service Task Force advises physicians to stop prescribing regular low doses of aspirin to patients at risk of a first heart attack or stroke. The new information amends the task force’s 2016 recommendation of initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD).

---

Click here to read to read the media release and additional background: Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease (PDF)

The Task Force is seeking comments on its draft recommendation statement, draft evidence review, and draft modeling report on aspirin use to prevent cardiovascular disease. People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 and older should not start taking aspirin. The draft recommendation statement, draft evidence review, and draft modeling report are available for review and public comment from October 12, 2021 to November 8, 2021 here.